Dr. Sander R. Dubovy, MD

Dr. Dubovy practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Dubovy's NPI, 1689617367, was assigned on June 13, 2006. Dr. Dubovy graduated from New York University School of Medicine in 1992. Dr. Dubovy holds Florida license ME81583.

Dr. Dubovy's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Dubovy's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Dubovy is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Dubovy to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dubovy practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Dubovy's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Dubovy is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Dubovy's licenses on file in 2 states: Florida and Illinois.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, dry eye, eyelid inflammation, glaucoma, retinal detachment and retinal occlusion among the conditions Dr. Dubovy treats.

CMS data shows 4,749 Medicare services from Dr. Dubovy across 17 procedure codes in 2024, for 1,111 Medicare patients. Medicare paid $147,339 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,111 Medicare patients who saw Dr. Dubovy in 2024. The largest group is 75 to 84, with 427 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dubovy's median patient age at 75, with 57% women.

In 2024, Dr. Dubovy wrote 397 Medicare Part D claims for 98 patients. 60% of them were for generic drugs. CMS names the drug for 331 of them, across 9 drugs with 11 or more claims each, at $20,169 in total drug cost. In 2023, CMS named 320 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Dubovy for performance year 2024, reported as part of a group. Dr. Dubovy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 295 papers to Dr. Dubovy, published from 2005 to 2025. 2020 was the busiest year, with 17. The most frequent topics are Visual Acuity, Tomography, Optical Coherence and Eye Neoplasms. Dr. Dubovy has published most often in Cornea. Dr. Dubovy's most frequent co-authors are Carol L. Karp, MD, Anat Galor, MD and Timothy G. Murray, MBA, MD.

CMS Open Payments shows 8 general payments to Dr. Dubovy from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $326.

Dmand AI lists 3 awards for Dr. Dubovy, most recently CMS Stage 1 EHR in 2014.

Dr. Dubovy graduated from New York University School of Medicine in 1992. Dr. Dubovy is a member of AAO and CAP.

Dr. Dubovy is in network with 13 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.